The Asia Pacific aortic valve replacement devices market is expected to grow from US$ 1,323.15 million in 2022 to US$ 3,489.38 million by 2030. It is estimated to grow at a CAGR of 12.9% from 2022 to 2030.
Advancements in Aortic Valve Replacement Devices Fuels Asia Pacific Aortic Valve Replacement Devices Market
The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.
A few technological advancements by the players in the aortic valve replacement devices are mentioned below:
• In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company's extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.
• In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.
• In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves. Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.
Asia Pacific Aortic Valve Replacement Devices Market Overview
The Asia Pacific aortic valve replacement devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region holds a significant share of the global aortic valve replacement devices market. The market in Asia Pacific is expected to witness significant growth during the forecast period due to factors such as rising elderly population, growing cardiovascular diseases, and innovative product availability.
Asia Pacific Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Aortic Valve Replacement Devices Market Segmentation
The Asia Pacific aortic valve replacement devices market is segmented into product, surgery, end user, and country.
Based on product, the Asia Pacific aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger Asia Pacific aortic valve replacement devices market share in 2022.
Based on surgery, the Asia Pacific aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger Asia Pacific aortic valve replacement devices market share in 2022.
Based on end user, the Asia Pacific aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest Asia Pacific aortic valve replacement devices market share in 2022.
Based on country, the Asia Pacific aortic valve replacement devices market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific aortic valve replacement devices market in 2022.
Abbott Laboratories, Artivion Inc, Boston Scientific Corp, Edwards Lifesciences Corp, LivaNova Plc, Medtronic Plc, and Venus MedTech HangZhou Inc, are some of the leading companies operating in the Asia Pacific aortic valve replacement devices market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,323.15 Million |
| Market Size by 2030 | US$ 3,489.38 Million |
| CAGR (2022 - 2030) | 12.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Aortic Valve Replacement Devices Market is valued at US$ 1,323.15 Million in 2022, it is projected to reach US$ 3,489.38 Million by 2030.
As per our report Asia Pacific Aortic Valve Replacement Devices Market, the market size is valued at US$ 1,323.15 Million in 2022, projecting it to reach US$ 3,489.38 Million by 2030. This translates to a CAGR of approximately 12.9% during the forecast period.
The Asia Pacific Aortic Valve Replacement Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Aortic Valve Replacement Devices Market report:
The Asia Pacific Aortic Valve Replacement Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Aortic Valve Replacement Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Aortic Valve Replacement Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Aortic Valve Replacement Devices Market
